GT
CVET

Glenmede Trust’s Covetrus, Inc. Common Stock CVET Stock Holding History

Glenmede Trust’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,692
Closed -$65K – 2444
2020
Q3 		$65K Buy
2,692
+39
+1% +$841 ﹤0.01% 1275
2020
Q2 		$47K Sell
2,653
-4,095
-61% -$53.8K ﹤0.01% 1332
2020
Q1 		$89K Hold
6,748
– – ﹤0.01% 1469
2019
Q4 		$89K Buy
6,748
+268
+4% +$3.25K ﹤0.01% 1469
2019
Q3 		$77 Sell
6,480
-26
-0.4% -$481 ﹤0.01% 1484
2019
Q2 		$159 Sell
6,506
-168,035
-96% -$4.84M ﹤0.01% 1247
2019
Q1 		$5.56K Buy
+174,541
New +$6.19M 0.03% 452

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
FCM
Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return

Glenmede Trust's CVET Position: Q4 2020 in Review

Glenmede Trust sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2020, closing a stake of 2,692 shares — an estimated $65K sold.

Glenmede Trust first reported a position in CVET in Q1 2019 and held it in 7 quarters. The position peaked at $89K in Q1 2020. 277 funds tracked by Wall St. Rank hold CVET as of Q4 2020.

  • Glenmede Trust reported no remaining Covetrus, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 2,692 Covetrus, Inc. Common Stock shares in Q4 2020, an estimated $65K.
  • Glenmede Trust first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 7 quarters.
  • Glenmede Trust's Covetrus, Inc. Common Stock position peaked at $89K in Q1 2020.
  • 277 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.